Skin and soft tissue infection: Necrotizing fasciitis

Current Opinion in Infectious Diseases

Volumn 11, Issue 2, 1998, Pages 119-123

  Low, Donald E ^a   McGeer, Allison ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; FOURNIER GANGRENE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; NECROTIZING FASCIITIS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; VIBRIO VULNIFICUS;

EID: 0031977324     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199804000-00005     Document Type: Article

References (47)

1. Singh G, Ray P, Sinha SK, Adhikary S, Khanna SK. Bacteriology of necrotizing infections of soft tissues. Aust NZ J Surg 1996; 66:747-750.
2. Bosshardt TL, Henderson VJ, Organ Jr CH. Necrotizing soft-tissue infections. Arch Surg 1996; 131:846-852; discussion 852-854.
3. Urschel JD, Takita H, Antkowiak JG. Necrotizing soft tissue infections of the chest wall. Ann Thorac Surg 1997; 64:276-279.
4. Chapnick EK, Abter EI. Necrotizing soft-tissue infections. Infect Dis Clin North Am 1996; 10:835-855. A good comprehensive review.
5. Somer T, Finegold SM. Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis 1995; 20:1010-1036.
6. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334:240-245.
7. Moses AE. Necrotizing fasciitis: flesh-eating microbes. Israel J Med Sci 1996; 32:781-784.
8. Kaul R, McGeer A, Low DE, Green K, Schwartz B, Ontario Group A Streptococcal study, Simor AE. Population-based surveillance for group A Streptococcal necrotizing fasciitis: clinical features, prognostic indicators and microbiologic analysis of 77 cases. Am J Med 1997; 103:18-24. There was a marked increase in necrotizing fasciitis during the winter of 1994-1995 (5-fold increase) that was associated with M3 strain. Almost haff of the patients were not bacteraemic. The mortality rate was 34%, with some protection with the use of intravenous immunoglobulin.
9. Meleney FL. Hemolytic Streptococcus gangrene. Arch Surg 1924; 9:317-364.
10. Lukomski S, Sreevatsan S, Amberg C, Reichardt W, Woischnik M, Podbielski A, Musser JM. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest 1997; 99:2574-2580. This study reports the importance of speB as a virulence factor.
11. Norrby-Teglund A, Lustig R, Kotb M. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates. Infect Immun 1997; 65:5209-5215.
12. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7.
13. Chelsom J, Halstensen A, Haga T, Hoiby EA. Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994; 344:1111-1115.
14. Ben-Aharon U, Borenstein A, Eisenkraft S, Lifschitz O, Leviav A. Extensive necrotizing soft tissue infection of the perineum. Israel J Med Sci 1996; 32:745-749.
15. Hejase MJ, Simonin JE, Bihrle R, Coogan CL. Genital Fournier's gangrene: experience with 38 patients. Urology 1996; 47:734-739.
16. Pizzorno R, Bonini F, Donelli A, Stubinski R, Medica M, Carmignani G. Hyperbaric oxygen therapy in the treatment of Fournier's disease in 11 male patients. J Urol 1997; 158:837-840.
17. Low DE, Schwartz B, McGeer A, Scheld WM, Armstrong D, Hughes JM, editors. The re-emergence of severe group A streptococcal disease: an evolutionary perspective, Chapter 7. In: Emerging Infections 1. Washington, DC: ASM Press; 1997. pp. 93-123. A comprehensive review of the factors which may account for the emergence of group A streptococci during the past decade.
18. Quirk WJJ, SternbachG. Joseph Jones: infection with flesh eating bacteria. J Emerg Med 1996; 14: 747-753.
19. Miller CW, Prescott JF, Mathews KA, Betschel SD, Yager JA, Guru V, Low DE. Streptococcal toxic shock syndrome in dogs. J Am Vet Med Assoc 1996; 209:1421-1426.
20. Bodemer C, Panhans A, Chretien-Marquet B, Cloup M, Pellerin D, de Prost Y. Staphylococcal necrotizing fasciitis in the mammary region in childhood: a report of five cases. J Pediatr 1997; 131:466-469.
21. Halow KD, Harner RC, Fontenelle LJ. Primary skin infections secondary to Vibrio vulnificus: the role of operative intervention. J Am Coll Surg 1996; 183:329-334. This study reports that patients at risk of Vibrio infections should avoid environments where vibrios may be present.
22. Furusu A, Yoshizuka N, Abe K, Sasaki O, Miyazaki K, Miyazaki M, et al. Aeromonas hydrophila necrotizing fasciitis and gas gangrene in a diabetic patient on haemodialysis. Nephrol Dial Transplant 1997; 12:1730-1734.
23. Schreuder F, Chatoo M. Another cause of necrotizing fasciitis? J Infect 1997; 35:177-178.
24. Zipper RP, Bustamante MA, Khatib R. Serratia marcescens: a single pathogen in necrotizing fasciitis. Clin Infect Dis 1996; 23:648-649.
25. Viani RM, Lewis A, Bradley JS. Postoperative group B streptococcal necrotizing fasciitis in a previously healthy child. Pediatr Infect Dis J 1997; 16:630-631.
26. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE, The Ontario Group A Streptococcal Study Group. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335:547-554.
27. Kiska DL, Thiede B, Caracciolo J, Jordan M, Johnson D, Kaplan EL, et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 1997; 176:992-1000. This study presents evidence that pharyngeal infections caused by one clone in the community may be the source of increased cases of streptococcal disease caused by the same clone.
28. Aebi C, Ahmed A, Ramilo O. Bacterial complications of primary varicella in children. Clin Infect Dis 1996; 23:698-705.
29. Outbreak of invasive group A streptococcus associated with varicella in a childcare center - Boston, Massachusetts, 1997. MMWR 1997; 46: 944-948.
30. + T cell profile from T(H2)-dominant type to T(H1)-dominant type after varicella-zoster virus infection in atopic dermatitis. J Allergy Clin Immunol 1997; 100:274-282.
31. Choo PW, Donahue JG, Platt R. Ibuprofen and skin and soft tissue superinfections in children with varicella. Ann Epidemiol 1997; 7:440-445. This study presents evidence that NSAIDs may not predispose patients to more severe group A streptococcal disease.
32. Talkington DF, Schwartz B, Black CM, Todd JK, Elliort J, Breiman RF, Facklam RR. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993; 61:3369-3374.
33. McGeer A, Green K, Schwartz B, Simor AE, Trpeski L, Tyrrell G, et al. Is necrotizing fasciitis a component of streptococcal toxic shock syndrome or a separate disease entity? - evidence from population-based surveillance in Ontario [abstract]. Interscience Conference on Antimicrobial Agents and Chemotherapy, 1997.
34. Becker M, Zbaren P, Hermans R, Becker CD, Marchal F, Kurt AM, et al. Necrotizing fasciitis of the head and neck: role of CT in diagnosis and management. Radiology 1997; 202:471-476.
35. Wysoki MG, Santora TA, Shah RM, Friedman AC. Necrotizing fasciitis: CT characteristics. Radiology 1997; 203:859-863.
36. Loh NN, Ch'en IY, Cheung LP, Li KC. Deep fascial hyperintensity in soft-tissue abnormalities as revealed by T2-weighted MR imaging. Am J Roentgenol 1997; 168:1301-1304. In this study, this powerful imaging technique was found to lack specificity. This information is very valuable for those looking for any type of diagnostic tool to help make difficult decisions regarding the management of patients with necrotizing fasciitis.
37. Majeski J, Majeski E. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J 1997; 90:1065-1068. In this study, the use of frozen sections of biopsies taken at the bedside were 100% sensitive and specific for the diagnosis of necrotizing fasciitis.
38. Hook III EW, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 1983; 249:1055-1057.
39. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60:759-770.
40. Kaul R, McGeer A, Canadian Infectious Diseases Society (CIDS), Ontario Group A Streptococcal Study, Norrby-Teglund A, Kotb M, Low DE. Intravenous immunoglobulin (IVIG) therapy in streptococcal toxic shock syndrome (STSS): results of a matched case-control study [abstract]. Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995.
41. Norrby-Teglund A, Kaul R, Low DE, McGeer A, Andersson J, Andersson U, Kotb M. Evidence for the presence of streptococcal superantigen neutralizing antibodies in normal polyspecific IgG (IVIG). Infect Immun 1996; 64:5395-5398. A report of a 20-year-old man with necrotizing fascirtis, who was treated successfully with high-dose IVIG. Evidence is provided that IVIG possess antibodies, which are able to neutralize those mitogenic factors, produced by the infecting strain of group A streptococci.
42. Norrby-Teglund A, Kaul R, Low DE, McGeer A, Newton DW, Andersson J, et al. Plasma from patients with severe group A streptococcal infections treated with normal polyspecific IgG (IVIG) inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol 1996; 156:3057-3064.
43. DiPersio JR, File Jr TM, Stevens DL, Gardner WG, Petropoulos G, Dinsa K. Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers. Clin Infect Dis 1996; 22:490-495.
44. McGeer A, Low DE, Davies HD, Schwartz B. Invasive group A streptococcal infections [letter to the editor]. N Engl J Med 1997; 336:514. This study found that subsequent cases of invasive group A streptococcal infection were likely to be of the same severity as the index case.
45. Gardam M, Low DE, Saginur R, Miller MA. Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults. Arch Int Med 1998; in press. A description of three cases of necrotizing fasciitis in non-pregnant adults.
46. Carmeli Y, Ruoff KL. Report of cases of and taxonomic considerations for large-colony-forming Lancefield group C streptococcal bacteremia. J Clin Microbiol 1995; 33:2114-2117.
47. Mouzin E, Mascola L, Tormey MP, Dassey DE. Prevention of Vibrio vulnificus infections. Assessment of regulatory educational strategies. JAMA 1997; 278:576-578.